George R. Ambalathingal
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis.
Journal: Clinical & translational immunology
Published: September 08, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Journal: Nature communications
Published: May 31, 2024
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.
Journal: Nature communications
Published: June 16, 2022
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.
Journal: PLoS pathogens
Published: March 01, 2022
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Journal: Microbiology spectrum
Published: February 24, 2022
Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine.
Journal: Clinical & translational immunology
Published: July 06, 2021
'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.
Journal: Journal for immunotherapy of cancer
Published: January 10, 2021
Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study.
Journal: The Journal of infectious diseases
Published: October 14, 2020
Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.
Journal: Clinical & translational immunology
Published: September 09, 2020
Last Updated: 09/26/2026